Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal

Novo shares have surged more than 20% amid oral Wegovy’s fast start. Elsewhere, Terns opened up room for a potential partnership and Corcept solidified its case for an ovarian cancer drug.

Continue reading →